设为首页    加入收藏   
首页期刊介绍编委会投稿须知稿约期刊订阅广告合作联系我们留言板

《中国冶金工业医学杂志》 欢迎访问,欢迎查询,欢迎引用!本刊已开通手机短信发送录用通知业务。敬告作者投稿成功的标志是收到手机短信和邮件回执。投稿出现问题邮箱wangtaohong@wangkantong.com,网站技术支持QQ1172987239。

本刊对投稿新要求:1.如果作者是第一次投稿,请务必用自己邮箱注册,并请认真填写作者单位详细通讯地址和第一作者手机,以便能及时准确收到杂志。2.文章必须有中文摘要,近5年参考文献至少3条。详见本刊投稿须知。本刊已同“中国知网”签订独家上网协议。

本刊2022年第3期杂志正在快递寄出,如果有作者没有收到杂志请与本刊快递员白先生联系,电话13304129493,说明第一作者姓名和联系方式。

本刊2022年第3期杂志基本信息已经登载在本刊网站,欢迎读者、作者查询引用。

贫血对晚期胃肠道肿瘤患者化疗疗效的影响
作者:丁利芳 
单位:内蒙古包钢医院肿瘤内科 内蒙古 包头 014010 
关键词:癌性贫血 化疗 晚期胃肠道肿瘤 化疗疗效 
分类号:R 735
出版年,卷(期):页码:2021,38(6):629-630
摘要:

 摘要:目的 分析晚期胃肠道肿瘤患者化疗前后血红蛋白(Hb)的变化以及与化疗疗效的关系。方法 回顾性分析我院治疗的75例晚期胃肠道肿瘤患者,按照Hb值水平将其分为化疗前后均无贫血组(组1)、化疗后伴有贫血组(组2)、化疗前后均有贫血组(组3),统计化疗前后Hb值变化情况及其对化疗疗效的影响。结果 3组化疗后Hb值均有所降低,且组2、组3化疗后Hb值与化疗前比较,差异均有统计学意义(均P<0.05);化疗4周期后,组1的OR值分别与组2、组3比较明显更高,组间比较差异均有统计学意义(均P<0.05)。结论 化疗可导致患者Hb降低,贫血可降低晚期胃肠道肿瘤患者化疗的疗效。

 Abstract:Objective To analyze the changes of hemoglobin(Hb)in patients with advanced gastrointestinal tumors before and after chemotherapy and its relationship with chemotherapy efficacy. Methods 75 cases with gastroenteric cancer were retrospectively analyzed. According to the Hb level, they were divided into Group 1 without anemia before and after chemotherapy, Group 2 with anemia after chemotherapy, and Group 3 with anemia group before and after chemotherapy. The statistics changes of Hb before and after chemotherapy and therapeutic effect were made. Results The Hb values of the three groups were all decrease after chemotherapy. The Hb value of Group 2 and Group 3 after chemotherapy were compared with that before chemotherapy, and the differences were statistically significant(all P<0.05); after 4 cycles of chemotherapy, the OR value of Group 1 was significantly higher compared with Group 2 and Group 3 respectively, and the differences between the groups were statistically significant(all P<0.05). Conclusion Chemotherapy can reduce the Hb, and anemia can reduce the efficacy of chemotherapy in patients with advanced gastrointestinal tumors.

基金项目:
作者简介:
参考文献:

 参考文献

[1] Ludwig H,Van Belle S,Barrett-Lee P,et al. The European Cancer Anaemia Survey (ECAS):a large,multinational,prospective survey defining the prevalence,incidence,and treatment of anaemia in cancer patients[J]. Eur J Cancer,2013,40(15):2293-2306.
[2] Qiu MZ,Xu RH,Ruan DY,et al. Incidence of anemia,leukocytosis,and thrombocytosis in patients with solid tumors in China[J]. Tumour Boil,2015,31(6):633-641.
[3] Blackwell K,Gascón P,Sigounas G,et al. rHuEPO and improved treatment
outcomes:potential modes of action[J]. Oncologist,2014,9(S5):41-47.
[4] Vaupel P,Mayer A,Briest S,et al. Oxygenation gain factor:a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers[J]. Cancer Res,2015,63(22):7634-7637.
[5] Semenza GL. HIF-1 and tumor progression:pathophysiology and therapeutics
[J]. Trends Mol Med,2014,8(S4):S62-67.
[6] Kim JG,Yi JM,Park SJ,et al. Histone demethylase JMJD2B-mediated cell proliferation regulated by hypoxia and radiation in gastric cancer cell[J]. Biochim Biophys Acta,2016,1819(11-12):1200-1207.
服务与反馈:
文章下载】【加入收藏
友情链接   中国知网-中国冶金工业医学杂志 搜狐邮箱 中国知网 中华预防医学会网站 国家新闻出版总署 博文采编官方网站 CNKI翻译助手 网易VIP163邮箱 网易126邮箱 网易163邮箱 雅虎邮箱 新浪邮箱 QQ邮箱 鞍钢总医院网站 丁香园 好医生 疾病查询

《中国冶金工业医学杂志》
编辑部地址:辽宁省鞍山市铁东区健身街3号(鞍钢总医院院内),邮编114002
电话:0412- 6327774 ,0412-6706630,传真:0412-6327774
网址:www.zgyjgyyxzz.com  邮箱:yjyx1984@vip.163.com
京ICP备10041176号